-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

4769 Ezh2 and Intracellular Ca2+ Signals Interdependently Coordinate Gvhd and CAR T Cell Responses

Program: Oral and Poster Abstracts
Session: 701. Experimental Transplantation: Basic and Translational: Poster III
Hematology Disease Topics & Pathways:
Research, Apoptosis, Fundamental Science, Translational Research, Immune mechanism, Immunology, Biological Processes, Molecular biology
Monday, December 9, 2024, 6:00 PM-8:00 PM

Ying WANG1*, Qingrong Huang2*, Ruqayyah sanders-Braggs3*, Yan Zhou, MS4*, Robert Hooper5*, Yuanyuan Tian, PhD6*, Tatiana Kent, PhD7*, Richard Pomerantz, PhD7*, Gennaro Clando8*, Jean-Pierre Issa8*, Jonathan Soboloff9* and Yi Zhang, MD, PhD6

1Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ
2Clinical Immunology Core, Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ
3Center for Discovery and Innovation, Hackensack University Medical Center, Nutley
4Fox Chase Cancer Center, Temple University, Philadelphia
5Temple University, Philadelphia, PA
6Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ
7Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
8Coriell Institute for Medical Research, Camden, NJ
9Temple University School of Medicine, Philadelphia, PA

Despite significant advances in graft-versus-host disease (GVHD) prevention and treatment, calcineurin inhibitor (CNI)-based standard GVHD prophylaxis in allogeneic hematopoietic stem cell transplantation (allo-HSCT) has limited efficacy in controlling acute and chronic GVHD. Thus, inhibition of calcium (Ca2+) signaling is insufficient to suppress the generation and maintenance of alloreactive T cells that mediate host tissue injury. Recent studies suggested that CNI-dependent alloreactive T cells possess great ability to persist and mediate chronic-like GVHD in mice. The molecular events by which these T cells breakthrough CNI inhibition have not been previously defined. Ezh2, a chromatin-modifying epigenetic regulator, silences expression of gene programs critical for multiple cellular processes. Ablating Ezh2 in T cells inhibits GVHD and anti-tumor activity, largely due to massive antigen-activated T cell death. Increased Ca2+ signals in activated T cells are known to induce their cell death and dysfunction. However, the relationship between Ezh2 and intracellular Ca2+ response generation in GVHD has never been previously examined. We report here that Ezh2 and Ca2+-mediated signals operate coordinately to regulate the viability and effector function of GVHD T cells. Blockade of Ca2+ signal by conditional deletion of Stim1, an endoplasmic reticulum (ER) Ca2+ sensor required for Ca2+ entry in T cells, rescued non-viable Ezh2-null alloreactive T cells, as well as restored their capacity to mediate GVHD in mice after allo-HSCT. Moreover, while STIM1-null T cells typically exhibit decreased effector differentiation and function of GVHD T cells, this was restored by deletion of Ezh2 in Stim1-null T cells. These data identify the interdependent roles of Ezh2 and Ca2+ signals in activation, effector differentiation and survival of alloreactive T cells. To understand how Ezh2 acts as ‘brake” for Ca2+ signals in T cells, we performed bulk-RNA-sequencing analysis on Ezh2/STIM1 dual knockout T cells. Ezh2 directly repressed expression Itpr2, which encodes the ER Ca2+ release channel 1,4,5-trisphosphate receptor (IP3R2), thereby interfering with ER Ca2+ release and subsequent cytosolic Ca2+ entry. Combined deletion of Ezh2 and Itpr2 genes restored the inability of allogeneic Ezh2-null T cells to induce lethal GVHD. Furthermore, the co-dependence of Ezh2 and Iptr2 were similarly observed in CD19-directed CAR-T mediated elimination of CD19-expressing C1498 acute myeloid leukemia in mice. Itpr2 loss in Ezh2-null CAR-T cells led to their improved survival, expansion, and production of IFN-g-producing effector CAR-T cells. Collectively, our findings identify that Ezh2 suppresses the expression of Iptr2 to prevent excessive Ca2+ signal generation and antigen-driven T cell death and T cell dysfunction. These observations reveal a potential therapeutic window for the treatment of GVHD focused on increasing intracellular Ca2+ signals to eliminate alloreactive T cells, which is opposing to the current concept of CNI treatment. Furthermore, targeting this Ezh2-Itpr2 axis may have broad implications in the regulation of other types of antigen-driven T cell responses, such as anti-tumor immunity, autoimmunity and graft rejection of solid organ transplantation.

Disclosures: No relevant conflicts of interest to declare.

*signifies non-member of ASH